PAIN
Volume 139, Issue 2 , Pages 458-466 , 15 October 2008

Medical history and the onset of complex regional pain syndrome (CRPS)

  • M. de Mos

      Affiliations

    • Erasmus University Medical Center, Pharmaco-epidemiology Unit, Departments of Medical Informatics and Epidemiology & Biostatistics, Room 2157, Dr. Molewaterplein 50, 3015 GE, Rotterdam, The Netherlands
    • Corresponding Author InformationCorresponding author. Tel.: +31 10 7044128; fax: +31 10 7044722.
    • ,
  • F.J.P.M. Huygen

      Affiliations

    • Erasmus University Medical Center, Department of Pain Treatment, ‘s Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands
    • ,
  • J.P. Dieleman

      Affiliations

    • Erasmus University Medical Center, Pharmaco-epidemiology Unit, Departments of Medical Informatics and Epidemiology & Biostatistics, Room 2157, Dr. Molewaterplein 50, 3015 GE, Rotterdam, The Netherlands
    • ,
  • J.S.H.A. Koopman

      Affiliations

    • Erasmus University Medical Center, Pharmaco-epidemiology Unit, Departments of Medical Informatics and Epidemiology & Biostatistics, Room 2157, Dr. Molewaterplein 50, 3015 GE, Rotterdam, The Netherlands
    • ,
  • B.H.Ch. Stricker

      Affiliations

    • Erasmus University Medical Center, Pharmaco-epidemiology Unit, Departments of Medical Informatics and Epidemiology & Biostatistics, Room 2157, Dr. Molewaterplein 50, 3015 GE, Rotterdam, The Netherlands
    • ,
  • M.C.J.M. Sturkenboom

      Affiliations

    • Erasmus University Medical Center, Pharmaco-epidemiology Unit, Departments of Medical Informatics and Epidemiology & Biostatistics, Room 2157, Dr. Molewaterplein 50, 3015 GE, Rotterdam, The Netherlands

Received 20 February 2008 ,Revised 27 May 2008 ,Accepted 3 July 2008.

References 

  1. Alessandri M, Massanti L, Geppetti P, Bellucci G, Cipriani M, Fanciullacci M. Plasma changes of calcitonin gene-related peptide and substance P in patients with dialysis headache. Cephalalgia. 2006;26:1287–1293
  2. Alexander GM, van Rijn MA, van Hilten JJ, Perreault MJ, Schwartzman RJ. Changes in cerebrospinal fluid levels of pro-inflammatory cytokines in CRPS. Pain. 2005;116:213–219
  3. Barnes PJ. Transcription factors in airway diseases. Lab Invest. 2006;86:867–872
  4. Beerthuizen A, Huygen FJPM, Wit Rd. De invloed van psychologische factoren op ontstaan en beloop van CRPS type 1-een systemisch literatuur onderzoek. Pijn info. 2004;15–28
  5. Birklein F, Schmelz M, Schifter S, Weber M. The important role of neuropeptides in complex regional pain syndrome. Neurology. 2001;57:2179–2184
  6. Birklein F. Complex regional pain syndrome. J Neurol. 2005;252:131–138
  7. Blair SJ, Chinthagada M, Hoppenstehdt D, Kijowski R, Fareed J. Role of neuropeptides in pathogenesis of reflex sympathetic dystrophy. Acta Orthop Belg. 1998;64:448–451
  8. Bradding P, Walls AF, Holgate ST. The role of the mast cell in the pathophysiology of asthma. J Allergy Clin Immunol. 2006;117:1277–1284
  9. Bruehl S, Carlson CR. Predisposing psychological factors in the development of reflex sympathetic dystrophy. A review of the empirical evidence. Clin J Pain. 1992;8:287–299
  10. Ciccone DS, Bandilla EB, Wu W. Psychological dysfunction in patients with reflex sympathetic dystrophy. Pain. 1997;71:323–333
  11. de Mos M, de Bruijn AG, Huygen FJ, Dieleman JP, Stricker BH, Sturkenboom MC. The incidence of complex regional pain syndrome: a population-based study. Pain. 2007;129:12–20
  12. De Vilder J. Personality of patients with Sudeck’s atrophy following tibial fracture. Acta Orthop Belg. 1992;58:252–257
  13. Fusayasu E, Kowa H, Takeshima T, Nakaso K, Nakashima K. Increased plasma substance P and CGRP levels, and high ACE activity in migraineurs during headache-free periods. Pain. 2007;128:209–214
  14. Fusco M, D’Andrea G, Micciche F, Stecca A, Bernardini D, Cananzi AL. Neurogenic inflammation in primary headaches. Neurol Sci. 2003;24:S61–S64
  15. Galer BS, Henderson J, Perander J, Jensen MP. Course of symptoms and quality of life measurement in complex regional pain syndrome: a pilot survey. J Pain Symptom Manage. 2000;20:286–292
  16. Groneberg DA, Quarcoo D, Frossard N, Fischer A. Neurogenic mechanisms in bronchial inflammatory diseases. Allergy. 2004;59:1139–1152
  17. Harden RN, Bruehl S, Galer BS, Saltz S, Bertram M, Backonja M, et al. Complex regional pain syndrome: are the IASP diagnostic criteria valid and sufficiently comprehensive?. Pain. 1999;83:211–219
  18. Hettne KM, de Mos M, de Bruijn AG, Weeber M, Boyer S, van Mulligen EM, et al. Applied information retrieval and multidisciplinary research: new mechanistic hypotheses in complex regional pain syndrome. J Biomed Discov Collab. 2007;2:2
  19. Huygen FJ, De Bruijn AG, De Bruin MT, Groeneweg JG, Klein J, Zijistra FJ. Evidence for local inflammation in complex regional pain syndrome type 1. Mediators Inflamm. 2002;11:47–51
  20. Huygen FJ, Ramdhani N, van Toorenenbergen A, Klein J, Zijlstra FJ. Mast cells are involved in inflammatory reactions during complex regional pain syndrome type 1. Immunol Lett. 2004;91:147–154
  21. Janig W, Baron R. Complex regional pain syndrome: mystery explained?. Lancet Neurol. 2003;2:687–697
  22. Karacan I, Aydin T, Ozaras N. Bone loss in the contralateral asymptomatic hand in patients with complex regional pain syndrome type 1. J Bone Miner Metab. 2004;22:44–47
  23. Leis S, Weber M, Isselmann A, Schmelz M, Birklein F. Substance-P-induced protein extravasation is bilaterally increased in complex regional pain syndrome. Exp Neurol. 2003;183:197–204
  24. Maihofner C, Handwerker HO, Neundorfer B, Birklein F. Patterns of cortical reorganization in complex regional pain syndrome. Neurology. 2003;61:1707–1715
  25. Manicourt DH, Brasseur JP, Boutsen Y, Depreseux G, Devogelaer JP. Role of alendronate in therapy for posttraumatic complex regional pain syndrome type I of the lower extremity. Arthritis Rheum. 2004;50:3690–3697
  26. Marie PJ, Hott M, Launay JM, Graulet AM, Gueris J. In vitro production of cytokines by bone surface-derived osteoblastic cells in normal and osteoporotic postmenopausal women: relationship with cell proliferation. J Clin Endocrinol Metab. 1993;77:824–830
  27. Marinus J, Van Hilten JJ. Clinical expression profiles of complex regional pain syndrome, fibromyalgia and a-specific repetitive strain injury: more common denominators than pain?. Disabil Rehabil. 2006;28:351–362
  28. Monti DA, Herring CL, Schwartzman RJ, Marchese M. Personality assessment of patients with complex regional pain syndrome type I. Clin J Pain. 1998;14:295–302
  29. Niehof SP, Huygen FJ, van der Weerd RW, Westra M, Zijlstra FJ. Thermography imaging during static and controlled thermoregulation in complex regional pain syndrome type 1: diagnostic value and involvement of the central sympathetic system. Biomed Eng Online. 2006;5:30
  30. O’Connor TM, O’Connell J, O’Brien DI, Goode T, Bredin CP, Shanahan F. The role of substance P in inflammatory disease. J Cell Physiol. 2004;201:167–180
  31. Perez RS, Zuurmond WW, Bezemer PD, Kuik DJ, van Loenen AC, de Lange JJ, et al. The treatment of complex regional pain syndrome type I with free radical scavengers: a randomized controlled study. Pain. 2003;102:297–307
  32. Pleger B, Ragert P, Schwenkreis P, Forster AF, Wilimzig C, Dinse H, et al. Patterns of cortical reorganization parallel impaired tactile discrimination and pain intensity in complex regional pain syndrome. Neuroimage. 2006;32:503–510
  33. Rauis AL. Psychological aspects. A series of 104 posttraumatic cases of reflex sympathetic dystrophy. Acta Orthop Belg. 1999;65:86–90
  34. Reuter U, Chiarugi A, Bolay H, Moskowitz MA. Nuclear factor-kappa B as a molecular target for migraine therapy. Ann Neurol. 2002;51:507–516
  35. Rommel O, Malin JP, Zenz M, Janig W. Quantitative sensory testing, neurophysiological and psychological examination in patients with complex regional pain syndrome and hemisensory deficits. Pain. 2001;93:279–293
  36. Sandroni P, Benrud-Larson LM, McClelland RL, Low PA. Complex regional pain syndrome type I: incidence and prevalence in Olmsted county, a population-based study. Pain. 2003;103:199–207
  37. Schattschneider J, Hartung K, Stengel M, Ludwig J, Binder A, Wasner G, et al. Endothelial dysfunction in cold type complex regional pain syndrome. Neurology. 2006;67:673–675
  38. Schinkel C, Gaertner A, Zaspel J, Zedler S, Faist E, Schuermann M. Inflammatory mediators are altered in the acute phase of posttraumatic complex regional pain syndrome. Clin J Pain. 2006;22:235–239
  39. Schrijvers AJP. Health and Healthcare in the Netherlands. A critical self-assesment of Dutch experts in medical and health sciences. Utrecht: De Tijdstroom; 1997;
  40. Stanton-Hicks M, Janig W, Hassenbusch S, Haddox JD, Boas R, Wilson P. Reflex sympathetic dystrophy: changing concepts and taxonomy. Pain. 1995;63:127–133
  41. Theoharides TC, Donelan J, Kandere-Grzybowska K, Konstantinidou A. The role of mast cells in migraine pathophysiology. Brain Res Brain Res Rev. 2005;49:65–76
  42. Toda K, Muneshige H, Maruishi M, Kimura H, Asou T. Headache may be a risk factor for complex regional pain syndrome. Clin Rheumatol. 2006;25:728–730
  43. van der Laan L, Veldman PH, Goris RJ. Severe complications of reflex sympathetic dystrophy: infection, ulcers, chronic edema, dystonia, and myoclonus. Arch Phys Med Rehabil. 1998;79:424–429
  44. van der Laan L, van Spaendonck K, Horstink MW, Goris RJ. The Symptom Checklist-90 Revised questionnaire: no psychological profiles in complex regional pain syndrome-dystonia. J Pain Symptom Manage. 1999;17:357–362
  45. van der Lei J, Duisterhout JS, Westerhof HP, van der Does E, Cromme PV, Boon WM, et al. The introduction of computer-based patient records in the Netherlands. Ann Intern Med. 1993;119:1036–1041
  46. Vaneker M, Wilder-Smith OH, Schrombges P, de Man-Hermsen I, Oerlemans HM. Patients initially diagnosed as ‘warm’ or ‘cold’ CRPS 1 show differences in central sensory processing some eight years after diagnosis: a quantitative sensory testing study. Pain. 2005;115:204–211
  47. Veldman PH, Reynen HM, Arntz IE, Goris RJ. Signs and symptoms of reflex sympathetic dystrophy: prospective study of 829 patients. Lancet. 1993;342:1012–1016
  48. Vlug AE, van der Lei J, Mosseveld BM, van Wijk MA, van der Linden PD, Sturkenboom MC, et al. Postmarketing surveillance based on electronic patient records: the IPCI project. Methods Inf Med. 1999;38:339–344
  49. Wu H, Guan C, Qin X, Xiang Y, Qi M, Luo Z, et al. Upregulation of substance P receptor expression by calcitonin gene-related peptide, a possible cooperative action of two neuropeptides involved in airway inflammation. Pulm Pharmacol Ther. 2007;20:513–524
  50. Zarrabeitia MT, Riancho JA, Amado JA, Napal J, Gonzalez-Macias J. Cytokine production by peripheral blood cells in postmenopausal osteoporosis. Bone Miner. 1991;14:161–167

PII: S0304-3959(08)00390-4

doi: 10.1016/j.pain.2008.07.002

PAIN
Volume 139, Issue 2 , Pages 458-466 , 15 October 2008

Article Tools